Pfizer Tries Injecting New Life Into Its Strategy With A Generic Injectables Unit

Entering the sterile injectables business is one step in Pfizer's efforts to buttress its mature products by diversifying into niche markets.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet